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Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Hegele RA, Retnakaran R, Zinman B, Hanley AJG:
Adipokines and incident type 2 diabetes in a Canadian Aborigine population: the Sandy Lake Health and Diabetes Project.
Diabetes Care 31:1410–1415, 2008
In the printed and early versions of this study, the term “Canadian Aborigine” appeared in the title and throughout the text of the
manuscript.Theuseofthistermwasbasedonachangetothemanuscriptthatwasmadebytheeditorialstaffwithoutapprovalfrom
or consultation with the authors. The authors and their community research partners do not use or support the use of this term in
any way and regret the appearance of this term in the study. The term “ Canadian Aborigine” has been replaced in the title and the
text of the online version with “Aboriginal Canadian,” which the authors feel is more appropriate and respectful terminology.
The Diabetes Care production staff extend their apologies to both the authors of the article and the Aboriginal Canadian
community for any misunderstanding or offense caused by this error.
Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE, for the Sitagliptin 036 Study Group: Effect of
initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in
patients with type 2 diabetes. Diabetes Care 30:1979–1987, 2007
InTable2ofthearticleabove,anasteriskwasmissingdenotingasigniﬁcantdifferencebetweenthe1,000mgmetforminb.i.d.group
and placebo. The corrected table appears on the following page. The online version reﬂects these changes.
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